Methicillin-resistant Staphylococcus aureus (MRSA) is a type of staph bacteria that is highly resistant to common antibiotics. Many people carry the MRSA bacteria harmlessly on their skin ...

Staphylococcus aureus (S. aureus) is a major cause of skin and soft tissue infections that can sometimes lead to sepsis and ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Methicillin-resistant Staphylococcus aureus (MRSA) is a type of staph bacteria highly resistant to common antibiotics. Around 1 in 3 people carry the bacteria on their skin or inside their noses.

aureus. Fortunately, a number of new agents active against MRSA and other Gram-positive pathogens have been developed and introduced into the clinics. Linezolid, daptomycin and tigecycline are ...

Staphylococcus aureus (S. aureus) is a major cause of skin and soft tissue infections that can sometimes lead to sepsis and ...

P-128 is under clinical development by GangaGen Biotechnologies and currently in Phase II for Staphylococcus aureus Infections.

Nurse loses leg after cutting foot, contracting bacterial infection while on Florida vacation SURPRISE, Ariz. ( KPHO /Gray ...

“It is a pathogen in dire need of control because it causes significant morbidity and mortality not just in the United States ...

The multivalent toxoid vaccine candidate from LimmaTech Biologics AG is designed to prevent skin and soft-tissue infections ...

Innoviva, Inc. (INVA) announced Monday that its unit Innoviva Specialty Therapeutics, Inc. or IST has entered into an exclusive ...